Skip to content

PLRX - PLIANT THERAPEUTICS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

Pliant Therapeutics Inc

PLRX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PLRXPliant Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $1.95
52-wk low: $1.02
Prev close: $1.52
Mkt cap: $72.4M
Beta: 1.27
P/S: 3071.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$11.5M

TS
Two Sigma
Q2 2026 13F
$2.6M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 9.1% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $72M

Valuation

P/S3071.82
P/B0.48

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PLRX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $72.45M
Beta: 1.27

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-50.3%

$2.4M

position

JS

Jim Simons

Q2 2026 13F

$2.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for PLRX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.36-9.1%

-$0.33 expected

Next report

What the street expects next

-50.3%

ROA-23.3%

Growth

Beta1.27